Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
Clinical trial NCT03368118 · COMPLETED
Trial details
- NCT number
- NCT03368118
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-20
- Primary completion
- 2022-07-12
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.